Brief: Enochian Biosciences Says Its Cancer Platform Remains On Track For Trials In Humans Following FDA Review

Lunai Bioworks

08/06/2023 15:22

June 8 (Reuters) - Enochian Biosciences Inc  ENOB.O :
    * ENOCHIAN BIOSCIENCES ANNOUNCES THAT ITS CANCER PLATFORM
REMAINS
ON TRACK FOR TRIALS IN HUMANS FOLLOWING FDA REVIEW
    * ENOCHIAN BIOSCIENCES INC - CONFIDENT IN SUBMITTING AN
INVESTIGATIONAL NEW DRUG APPLICATION (IND) FOR ITS INNOVATIVE
CANCER PLATFORM IN EARLY/MID 2024

Source text for Eikon:  ID:nGNE8g0qcX 
Further company coverage:  ENOB.O 

 ((Reuters.Briefs@thomsonreuters.com;))